McCune-Albright syndrome

Revision as of 18:17, 18 August 2020 by Dushka (talk | contribs) (→‎Symptoms)
Jump to navigation Jump to search
McCune-Albright syndrome
ICD-10 Q78.1
ICD-9 756.54
OMIM 174800
DiseasesDB 7880
MedlinePlus 001217
eMedicine ped/1386 
MeSH D005359

WikiDoc Resources for McCune-Albright syndrome

Articles

Most recent articles on McCune-Albright syndrome

Most cited articles on McCune-Albright syndrome

Review articles on McCune-Albright syndrome

Articles on McCune-Albright syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on McCune-Albright syndrome

Images of McCune-Albright syndrome

Photos of McCune-Albright syndrome

Podcasts & MP3s on McCune-Albright syndrome

Videos on McCune-Albright syndrome

Evidence Based Medicine

Cochrane Collaboration on McCune-Albright syndrome

Bandolier on McCune-Albright syndrome

TRIP on McCune-Albright syndrome

Clinical Trials

Ongoing Trials on McCune-Albright syndrome at Clinical Trials.gov

Trial results on McCune-Albright syndrome

Clinical Trials on McCune-Albright syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on McCune-Albright syndrome

NICE Guidance on McCune-Albright syndrome

NHS PRODIGY Guidance

FDA on McCune-Albright syndrome

CDC on McCune-Albright syndrome

Books

Books on McCune-Albright syndrome

News

McCune-Albright syndrome in the news

Be alerted to news on McCune-Albright syndrome

News trends on McCune-Albright syndrome

Commentary

Blogs on McCune-Albright syndrome

Definitions

Definitions of McCune-Albright syndrome

Patient Resources / Community

Patient resources on McCune-Albright syndrome

Discussion groups on McCune-Albright syndrome

Patient Handouts on McCune-Albright syndrome

Directions to Hospitals Treating McCune-Albright syndrome

Risk calculators and risk factors for McCune-Albright syndrome

Healthcare Provider Resources

Symptoms of McCune-Albright syndrome

Causes & Risk Factors for McCune-Albright syndrome

Diagnostic studies for McCune-Albright syndrome

Treatment of McCune-Albright syndrome

Continuing Medical Education (CME)

CME Programs on McCune-Albright syndrome

International

McCune-Albright syndrome en Espanol

McCune-Albright syndrome en Francais

Business

McCune-Albright syndrome in the Marketplace

Patents on McCune-Albright syndrome

Experimental / Informatics

List of terms related to McCune-Albright syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

McCune-Albright syndrome is a rare genetic disorder caused by an activating mutation of the GNAS gene resulting in various phenotypic presentations. MAS typically presents with the triad of polyostotic fibrous dysplasia, precocious puberty and café au lait spots in both genders. Other manifestations include hyperthyroidism, acromegaly and Cushing’s syndrome.[1]

Historical Perspective

  • McCune-Albright syndrome was first discovered by physicians Donovan McCune and Fuller Albright in 1937. [2]

Classification

Pathophysiology

  • The pathogenesis of McCune-Albright syndrome is characterized by increased cAMP signaling in bone, skin and endocrine tissues. In bone osteoblasts differentiation results in fibrous dysplasia. In the skin there is stimulation of melanin production resulting in café au lait macules with irregular borders. In endocrine tissues increased cAMP results in increased production of hormones depending on which tissue is affected including the gonads, thyroid, parathyroid, pituitary and adrenal glands.[1]
  • The GNAS gene mutation has been associated with the development of McCune-Albright syndrome, involving the cAMP pathway-associated G-protein, Gsα. The various tissues involved in the syndrome is a result of the ubiquitous signaling of Gsα. [3]

Causes

McCune-Albright syndrome is caused by a missense mutation of the GNAS gene alpha subunit which becomes constitutively activated. This increases intracellular cAMP which activates downstream hormones resulting in multiple tissue types being affected and mosaicism presented in its patients. [1]

Differentiating McCune-Albright syndrome from other Diseases

For further information about the differential diagnosis, click here

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

  • If left untreated patients may progress to develop decreased adult stature as a result of precocious puberty. [1]
  • Common complications of McCune-Albright syndrome include rickets because of phosphate wasting and pain and fractures at fibrous dysplasia sites. [1]

Diagnosis

Diagnostic Criteria

  • The diagnosis of McCune-Albright syndrome is a clinical diagnosis. [1]
  • Though there are genetic tests available for the GNAS gene mutation with new PCR techniques for those who show clinical signs of the syndrome. [4]
  • Patients who present with monostotic fibrous dysplasia are required to have evidence of the pathogenic GNAS gene my molecular testing [3]

Symptoms

Café au lait spot in McCune Albright syndrome with coast of Maine irregular borders
  • Symptoms of McCune-Albright syndrome include the following:
    • Precocious puberty
      • In girls presenting with ovarian cysts with vaginal bleeding and breast development [4]
      • In boys presenting with acne, body odor, pubic hair and penile enlargement [4]
      • Both genders with gonadal pathologies [4]
    • Fibrous dysplasia leading to pathologic fractures or pain [1]
    • Café au lait spots with “coast of Maine” irregular borders [1] and are often the first presenting sign [3]
    • Possible hyperthyroidism, Cushing syndrome, acromegaly or prolactin secretion due to increased thyroid, cortisol, growth hormone or prolactin secretion respectively [1]
    • Phosphate wasting with or without hypophosphatemia [3]

Physical Examination

Laboratory Findings

  • Girls will have raised estradiol levels indicating an activated hypothalamic-pituitary axis.
  • Other laboratory findings consistent with the diagnosis of McCune-Albright syndrome are elevated growth hormone which can be deduced by an oral glucose tolerance test, serum GH and prolactin measurements.
  • Evaluation of hyperthyroidism is indicated by measuring TSH, free and bound thyroxine and T3.
  • It is worth monitoring levels of serum phosphate and renal absorption of phosphate. [1]

Electrocardiogram

X-ray

The fibrous dysplasia of bone is present at multiple sites (polyostotic) and xrays would give a ground glass appearance. [4]

Echocardiography or Ultrasound

US in boys may be helpful in the diagnosis of McCune-Albright syndrome. Findings on an US suggestive of McCune-Albright syndrome include testicular ultrasounds to identify hormonally active tumors.[1]

CT scan

CT scan may be helpful in the diagnosis of McCune-Albright syndrome. Findings on CT scan suggestive of/diagnostic of McCune-Albright syndrome include fibroblastic lesions. It is helpful to identify these early in children to prevent permanent deformities. [1]

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

  • The treatment for McCune Albright syndrome includes:
    • Precocious puberty- prevent bone age advancement [3]
      • For girls- Letrozole (aromatase inhibitor) and or tamoxifen (estrogen receptor modulator) [4]
    • Fibrous dysplasia – minimize morbidity related to pain and fractures: [3]
      • Bisphosphonates have been used for fibrous dysplasia pain. [4]
    • Endocrinopathies
      • Thyroid disease – Methimazole is effective [3]
      • Increased Growth hormone
        • Octeotride which acts as a somatostatin analog and should be monitored for signs and symptoms of gallbladder disease [3]
        • Pegvisomant which is a growth hormone receptor antagonist and should be monitored for hepatotoxicity [3]

Surgery

Prevention

  • Once diagnosed patients with McCune-Albright syndrome are followed-up with:
    • Females – early breast cancer screening [3]
    • Males – testicular lesions by physical examination and US [3]
    • Both genders – signs of precocious puberty, growth hormone excess or growth acceleration, monitoring thyroid function, radiographs for fibrous dysplasia lesions particularly to check for scoliosis, serum phosphorous to monitor for development of hypophosphatemia [3] and regular vision and hearing testing to monitor fibrotic lesions affecting these areas. [1]
    • Parents should be counseled that McCune-Albright syndrome is not inherited [3]

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 "StatPearls". 2020. PMID 30725777.
  2. Manring MM, Calhoun JH (2011). "Biographical sketch: Fuller Albright, MD 1900-1969". Clin Orthop Relat Res. 469 (8): 2092–5. doi:10.1007/s11999-011-1831-0. PMC 3126964. PMID 21384213.
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K; et al. (1993). "GeneReviews®". PMID 25719192.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL; et al. (2012). "Medical Genetics Summaries". PMID 28520344.

See also

External links

it:Sindrome di McCune-Albright-Sternberg

Template:WH Template:WikiDoc Sources